Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug. Cheaper competition to off-patent Advair has been ...
ASX-listed gold/copper explorer Artemis Resources is on the hunt for a cash injection to ramp up drilling activities at its WA resources projects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback